Vitamin D deficiency in head and neck cancer patients – prevalence, prognostic value and impact on immune function

By F. Bochen, Benedikt Balensiefer, S. Körner, J. Bittenbring, F. Neumann, Armand Koch, K. Bumm, A. Marx, S. Wemmert, Georgios Papaspyrou and 5 more. 2018

Subfields: Oncology, Otorhinolaryngology

Citations in the corpus

• Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas (2024, unknown): “In the context of possible adjuvants, vitamin D has been shown in preclinical and retrospective clinical studies to be a positive prognostic marker, as well as a possible agent for increasing response rates due to its immunomodulatory properties [11,12].”
• Vitamin D and Clinical Outcomes in Head and Neck Cancer: A Systematic Review (2025, unknown): “Several studies within this review [27–29, 33,”